TUMOUR CELL MOBILISATION

TUMOUR CELL MOBILISATION was reported 10 times

TUMOUR CELL MOBILISATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DUVELISIB 3 0.0035
1 GILTERITINIB 3 0.0007
2 DECITABINE 3 0.0007
3 PONATINIB HYDROCHLORIDE 3 0.0006
4 DASATINIB 3 0.0003
5 BLEOMYCIN SULFATE 3 0.0003
6 BLINATUMOMAB 3 0.0003
7 SIROLIMUS 3 0.0002
8 MELPHALAN HYDROCHLORIDE 3 0.0001
9 NILOTINIB 3 0.0001
10 AZACITIDINE 3 0.0001
11 REGORAFENIB 1 0.0001
12 GEMCITABINE HYDROCHLORIDE 3 0.0001
13 LEDIPASVIR AND SOFOSBUVIR 1 0.0001
14 CYTARABINE 3 0.0000
15 OLAPARIB 1 0.0000
16 DEFERASIROX 1 0.0000
17 IBRUTINIB 3 0.0000
18 TACROLIMUS OINTMENT 0.1% 4 0.0000
19 TACROLIMUS EXTENDED-RELEASE CAPSULES 4 0.0000
20 NIVOLUMAB 3 0.0000
21 TACROLIMUS 4 0.0000
22 IRBESARTAN 1 0.0000
23 RIBAVIRIN 1 0.0000
24 RITUXIMAB 3 0.0000
25 UPADACITINIB 1 0.0000
26 CLOPIDOGREL BISULFATE 1 0.0000
27 ZOLPIDEM TARTRATE 1 0.0000
28 METHYLPREDNISOLONE 1 0.0000
29 METHOTREXATE SODIUM 3 0.0000
30 LANSOPRAZOLE 1 0.0000
31 PREDNISONE 1 0.0000